What vitamin B6’s active form (PLP) reveals about enzyme fidelity, neurological resilience, and why ‘more B6’ isn’t always the right answer.
The B Vitamin We Thought We Understood
Ask any clinician to name the functions of vitamin B6, and you’ll hear the usual suspects: amino acid metabolism, neurotransmitter synthesis, perhaps a nod to its role in methylation. But as we continue to study pyridoxal 5’-phosphate (PLP)—the bioactive form of B6—it becomes clear that we’ve vastly underestimated both its functional scope and its fragility.
PLP is one of the most reactive molecules in human biochemistry. It doesn’t just act; it interacts—with enzymes, neurotransmitters, dietary amino acids, and alarmingly, with endogenous toxins and drug metabolites. And when these interactions go wrong—due to genetic mutations, medication, or metabolic overload—the clinical consequences can range from mild neuropathy to devastating neonatal seizures.
So the question becomes: what happens when the body’s most versatile cofactor loses control?
